维力医疗收盘上涨2.64%，滚动市盈率15.32倍，总市值32.98亿元

Group 1 - The core viewpoint of the news highlights the current stock performance and valuation metrics of Weili Medical, indicating a low PE ratio compared to the industry average [1][3] - As of April 22, Weili Medical's stock closed at 11.26 yuan, with a 2.64% increase, and a rolling PE ratio of 15.32, marking a new low in 13 days [1] - The total market capitalization of Weili Medical is reported at 3.298 billion yuan, with an increase in the number of shareholders to 18,292, averaging a holding value of 352,800 yuan per shareholder [1] Group 2 - Weili Medical specializes in the research, production, and sales of medical devices in various fields including anesthesia, urology, and respiratory care [2] - The company reported a revenue of 1.06 billion yuan for the third quarter of 2024, reflecting an 8.53% year-on-year increase, and a net profit of 167 million yuan, up 15.85% year-on-year, with a gross margin of 44.80% [2] - In terms of industry comparison, the average PE ratio for the medical device sector is 48.08, with a median of 30.21, positioning Weili Medical at the 33rd rank within the industry [3]